About   Help   FAQ
Gene Expression Data
Assay Details
Assay
Reference: J:244447 Li B, et al., Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome. Mol Genet Genomic Med. 2016 Jan;4(1):95-105
Assay type: RNA in situ
MGI Accession ID: MGI:6121143
Gene symbol: Mid1
Gene name: midline 1
Probe: Mid1 oligo1
Probe preparation: Antisense labelled with digoxigenin RNA
Visualized with: Alkaline phosphatase
Results
Specimen 4A: embryonic day 10.5 (more )
Structure Level Pattern Image Note
TS17: 1st branchial arch mandibular component ectoderm Strong 4A
TS17: 1st branchial arch maxillary component ectoderm Strong 4A
TS17: 1st branchial arch mandibular component mesenchyme Strong Regionally restricted 4A Expression is in the mesenchyme adjacent to the epithelium.
TS17: 1st branchial arch maxillary component mesenchyme Strong Regionally restricted 4A Expression is in the mesenchyme adjacent to the epithelium.
TS17: nasal pit epithelium Strong Regionally restricted 4A Expression is in the dorsal-most border of nasal pit.
Specimen 4B: embryonic day 10.5 (more )
Structure Level Pattern Image Note
TS17: latero-nasal process ectoderm Strong 4B Expression is stronger in the distal ends.
TS17: medial-nasal process ectoderm Strong 4B Expression is stronger in the distal ends.
TS17: latero-nasal process mesenchyme Strong Regionally restricted 4B Expression is in the mesenchyme adjacent to the epithelium and is stronger at the distal ends.
TS17: medial-nasal process mesenchyme Strong Regionally restricted 4B Expression is in the mesenchyme adjacent to the epithelium and is stronger at the distal ends.
Specimen 5A: embryonic day 10.5 (more )
Structure Level Pattern Image Note
TS17: latero-nasal process ectoderm Strong 5A Expression is stronger in the distal ends.
TS17: medial-nasal process ectoderm Strong 5A Expression is stronger in the distal ends.
TS17: latero-nasal process mesenchyme Strong Regionally restricted 5A Expression is in the mesenchyme adjacent to the epithelium. Expression is stronger in the distal ends.
TS17: medial-nasal process mesenchyme Strong Regionally restricted 5A Expression is in the mesenchyme adjacent to the epithelium. Expression is stronger in the distal ends.
TS17: forebrain Strong 5A
TS17: hindbrain Strong 5A
Specimen 5B: embryonic day 10.5 (more )
Structure Level Pattern Image Note
TS17: latero-nasal process ectoderm Strong Regionally restricted 5B Expression is stronger in the distal ends at the putative site of fusion.
TS17: latero-nasal process mesenchyme Strong Regionally restricted 5B Expression is stronger in the distal ends at the putative site of fusion.
TS17: medial-nasal process ectoderm Strong Regionally restricted 5B Expression is stronger in the distal ends at the putative site of fusion.
TS17: medial-nasal process mesenchyme Strong Regionally restricted 5B Expression is stronger in the distal ends at the putative site of fusion.
Specimen 5C: embryonic day 10.5 (more )
Structure Level Pattern Image Note
TS17: latero-nasal process ectoderm Weak Regionally restricted 5C After fusion expression at the distal ends is downregulated.
TS17: latero-nasal process mesenchyme Weak Regionally restricted 5C After fusion expression at the distal ends is downregulated.
TS17: medial-nasal process ectoderm Weak Regionally restricted 5C After fusion expression at the distal ends is downregulated.
TS17: medial-nasal process mesenchyme Weak Regionally restricted 5C After fusion expression at the distal ends is downregulated.
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
05/07/2024
MGI 6.23 		The Jackson Laboratory